Long COVID results from several overlapping biological processes that can persist for months or years after the initial SARS-CoV-2 infection. There isn’t a single cause. Instead, researchers have identified at least five distinct mechanisms that can work alone or together: lingering virus in tissues, immune system misfires, tiny blood clots that starve tissues of oxygen, damaged cellular energy production, and reactivation of dormant viruses already in your body. About 29% of Americans who’ve had COVID-19 report symptoms lasting three months or longer, and understanding why it happens is the first step toward better treatment.
The Virus Doesn’t Always Leave
One of the strongest explanations for Long COVID is that fragments of the virus, and sometimes active virus, hide in tissues long after you test negative on a nasal swab. Autopsy studies have found SARS-CoV-2 RNA and viral protein in dozens of body sites up to 230 days after infection, even in people who had mild COVID. Over half of those cases showed persistent viral material in lymph nodes from the head, neck, and chest, as well as in the sciatic nerve, eye tissue, and multiple regions of the brain and spinal cord. One study found viral RNA in 80% of lung tissue samples taken up to 174 days after illness.
The virus also turns up in unexpected places. Researchers have detected it in skin, appendix, and breast tissue more than 400 days after the initial infection. In patients with persistent loss of smell, viral RNA and protein were found in the tissue lining the nasal cavity months after standard nasal swab tests came back negative. This suggests the virus can retreat to tissue reservoirs that routine testing simply can’t reach, quietly driving inflammation and symptoms from hiding.
The Immune System Turns on Itself
In some people, the intense immune response to SARS-CoV-2 goes off track and starts producing antibodies that attack the body’s own tissues. These autoantibodies have been found targeting receptors involved in nervous system signaling, including receptors that control neurotransmitter activity. That matters because it could explain neurological symptoms like brain fog, fatigue, and dizziness that have no obvious structural cause on a brain scan.
This kind of immune confusion isn’t unique to COVID. Similar autoantibody patterns appear in other post-infectious conditions like chronic fatigue syndrome and chronic Lyme disease. What makes Long COVID notable is the scale: millions of people were infected in a short window, creating a large population in which autoimmune processes could take hold. The autoantibodies appear to persist well beyond the acute infection, which helps explain why symptoms can last months or years even after the virus is no longer detectable in standard tests.
Microclots That Block Oxygen Delivery
One of the more striking findings in Long COVID research involves abnormal blood clots too small to see without a microscope. These aren’t the dangerous clots that cause strokes or pulmonary embolisms. They’re tiny structures, typically between 1 and 200 micrometers across, made of a misfolded, unusually tough form of the clotting protein fibrin. Researchers call them fibrin amyloid microclots because the protein takes on the same rigid, sticky structure seen in amyloid diseases like Alzheimer’s.
At that size, these microclots can physically plug capillaries, the smallest blood vessels where red blood cells deliver oxygen to tissues. When capillaries get blocked, the tissues downstream are starved of oxygen. This single mechanism could plausibly explain a wide range of Long COVID symptoms: the crushing fatigue, exercise intolerance, brain fog, and muscle pain all share a common thread of tissues not getting enough oxygen to function properly. The microclots are also unusually resistant to the body’s normal clot-dissolving systems, which may be why symptoms persist for so long.
Cells Can’t Produce Enough Energy
Your cells generate energy through mitochondria, small structures that convert food and oxygen into the fuel your body runs on. In Long COVID patients, this process is measurably impaired. Studies of immune cells from people with lingering symptoms show abnormal cellular respiration and reduced energy production. Brain and muscle scans using specialized imaging have revealed similar problems in those tissues.
The downstream effects are widespread. Blood tests in Long COVID patients show elevated markers of oxidative stress (a sign that cells are producing harmful byproducts instead of clean energy) alongside reduced levels of protective compounds like coenzyme Q10 that normally keep mitochondria running smoothly. This energy deficit helps explain why many people with Long COVID describe hitting a wall during physical or mental exertion. Their cells literally cannot keep up with demand. The connection between mitochondrial damage and specific symptoms is becoming clearer too: patients with post-COVID dizziness, for example, show significantly higher blood levels of a protein released when mitochondria are under stress.
Dormant Viruses Wake Up
Most adults carry several latent viruses that were picked up earlier in life and normally kept in check by the immune system. Epstein-Barr virus, which causes mono, is the most common: roughly 90% of adults worldwide carry it. When COVID-19 disrupts immune function, these dormant viruses can reactivate and start multiplying again.
In one study comparing Long COVID patients to people who fully recovered from their infection, Epstein-Barr virus DNA was detected in throat samples of 50% of the Long COVID group, compared to just 20% of recovered patients. Importantly, blood tests confirmed these were reactivations of old infections, not new ones. The reactivated virus adds its own inflammatory burden on top of whatever SARS-CoV-2 is still doing, potentially compounding fatigue, sore throats, and swollen lymph nodes. This may be one reason Long COVID symptoms can wax and wane unpredictably: flares could partly reflect cycles of viral reactivation and suppression.
The Vagus Nerve and Brain Inflammation
The vagus nerve is the longest nerve in your body, running from your brainstem down through your chest and abdomen. It acts as a major communication highway between your brain and your organs, and it plays a critical role in keeping inflammation in check throughout the body. Post-mortem studies have confirmed that SARS-CoV-2 can directly infect the vagus nerve, causing significant neuroinflammation.
When the vagus nerve is damaged, its ability to suppress inflammation drops. This creates a vicious cycle: the body’s natural braking system for inflammation is weakened at the exact moment inflammation needs to be controlled. Higher levels of virus in the nerve correlate with reduced activity in genes responsible for neurotransmitter signaling and nerve communication, suggesting a dose-dependent relationship. On top of direct damage, autoantibodies targeting receptors involved in the vagus nerve’s anti-inflammatory signaling have been found in COVID-19 survivors, meaning the nerve can be functionally impaired even without structural damage.
This mechanism connects to many hallmark Long COVID symptoms. The vagus nerve regulates heart rate, digestion, and breathing, so damage to it can produce the rapid heartbeat on standing, gastrointestinal problems, and shortness of breath that patients commonly report. It also connects to brain regions involved in processing stress, emotion, and cognition, which may contribute to brain fog and the difficulty concentrating that many describe.
Gut Bacteria Shifts That Persist
People with Long COVID consistently show a disrupted gut microbiome compared to those who recovered fully. The pattern is specific: beneficial bacteria that produce short-chain fatty acids, compounds that nourish the gut lining and calm inflammation, are depleted. Species like Faecalibacterium prausnitzii and several Bifidobacterium strains show the strongest inverse correlation with Long COVID development, meaning the lower their levels, the more likely someone is to have persistent symptoms.
At the same time, inflammatory and opportunistic bacteria flourish. A study of 106 patients with lingering symptoms found increases in species known to promote gut inflammation. These imbalances aren’t just a side note. In a six-month follow-up study, neuropsychiatric symptoms and fatigue were specifically linked to the overgrowth of certain pathogenic bacteria, while persistent respiratory symptoms tracked with increases in different opportunistic species. The gut microbiome communicates directly with the immune system and the brain through the vagus nerve, so these bacterial shifts may amplify the immune dysfunction and neuroinflammation described above.
Who Faces the Highest Risk
Several factors increase the likelihood of developing Long COVID. The severity of the initial infection matters: people hospitalized with COVID-19 are more likely to have lingering symptoms than those with mild cases, though Long COVID absolutely occurs after mild infections too. Women are diagnosed with Long COVID at higher rates than men, a pattern that mirrors other post-infectious and autoimmune conditions. Having more underlying health conditions raises risk, with the probability increasing alongside the number of pre-existing issues like diabetes, heart disease, chronic lung disease, or kidney disease.
Vaccination offers meaningful but incomplete protection. A meta-analysis of multiple studies found that vaccinated individuals had roughly 23% lower odds of developing Long COVID compared to unvaccinated people. Booster doses provided additional benefit, reducing odds by about 26% compared to no vaccination and significantly outperforming a primary vaccine series alone. This suggests vaccination blunts but does not eliminate the biological processes that lead to persistent symptoms.
Why These Causes Overlap
These mechanisms don’t operate in isolation. Persistent virus in the gut could drive the microbiome changes. Microclots blocking capillaries could starve mitochondria of the oxygen they need to produce energy. Vagus nerve damage could reduce the body’s ability to rein in the autoimmune response. A single patient might have two, three, or more of these processes running simultaneously, which helps explain why Long COVID looks so different from person to person. One person’s primary problem might be microclots causing exercise intolerance, while another’s might be autoantibodies driving neurological symptoms.
This complexity is also why no single treatment has emerged as a universal fix. The condition likely requires different interventions depending on which mechanisms are dominant in each individual, and researchers are actively working to develop tests that can distinguish between these subtypes. The global prevalence of Long COVID sits at roughly 36% of all confirmed infections, making it one of the largest mass-disabling events in modern medicine and one of the most urgent puzzles in current biomedical research.